drugset / Trial / NCT05334043
Pharmacokinetics and Bioavailability of Curcumin UP 30 Capsules in Healthy Adult Subjects
Phase 1
Unknown
12 enrolled
The Affiliated Hospital of Qingdao University
Chenland Nutritionals Inc. · collab
RandomizedCrossoverOpen-labelPrevention
Summary
A single-center, open-label, randomized, two-period, crossover study design of pharmacokinetics and bioavailability in healthy adult male and female subjects under fasting conditions.
Timeline
- Start
- 2022-03-23
- Primary completion
- 2022-04-07
- Completion
- 2022-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CuminUP30 | Unknown | 3500 mg | — |
| Subject | Curcumin capsules | Unknown | 2250 mg | — |
Indications
No indication recorded.